Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis?
Open Access
- 16 October 2002
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 46 (10) , 2549-2552
- https://doi.org/10.1002/art.10586
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritisArthritis & Rheumatism, 2002
- Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13Arthritis & Rheumatism, 2002
- Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in miceJournal of Clinical Investigation, 2001
- Evidence for altered synthesis of type II collagen in patients with osteoarthritis.Journal of Clinical Investigation, 1998
- Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.Journal of Clinical Investigation, 1997
- Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.Journal of Clinical Investigation, 1997
- Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration.Journal of Clinical Investigation, 1995
- Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay.Journal of Clinical Investigation, 1994
- Generalized osteoarthritis associated with increased insulin‐like growth factor types i and ii and transforming growth factor β in cortical bone from the iliac crest. possible mechanism of increased bone density and protection against osteoporosisArthritis & Rheumatism, 1993
- Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease.Journal of Clinical Investigation, 1992